DKK1 and hepatocellular carcinoma: Fourth, our mechanistic studies are the first to report that SOR combined with DKK1 inhibitor treatment synergistically inhibited the PI3K/Akt and Wnt/β-catenin pathways by regulation of GSK3β in HCC.